Verona Pharma plc

Ownership Transactions Reported by 19 Insiders

Symbol: VRNA on Nasdaq
Industry: Pharmaceutical Preparations
Location: 3 More London Riverside, London, United Kingdom

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+101K	1.8%	$4.70	+$476K
Sells	3	-5.56M	98.2%	$4.45	-$24.7M
Net	-1	-5.45M	-96.4%		-$24.2M

Verona Pharma plc executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Access Industries Holdings LLC	10%+ Owner	$110M			Aug 15, 2022
David Zaccardelli	President and CEO, Director	$102M	-$10.8M	-9.55%	Feb 1, 2025
Mark Hahn	Chief Financial Officer	$95.5M	-$12M	-11.2%	Feb 1, 2025
Kathleen A. Rickard	Chief Medical Officer	$21.8M	-$1.91M	-8.06%	Mar 12, 2025
Rishi Gupta	Director	$7.46M			May 11, 2023
Orbimed Advisors Llc	Director	$7.46M			May 11, 2023
Claire Poll	General Counsel	$5.53M			Feb 1, 2024
David R. Ebsworth	Director	$2.58M	+$278K	+12%	Feb 26, 2025
Andrew Fisher	General Counsel	$1.31M			Oct 30, 2024
Martin Edwards	Director	$286K			Apr 29, 2024
Christina Ackermann	Director	$198K	+$198K		Nov 6, 2024
Vikas Sinha	Director				Apr 29, 2024
Andrew Sinclair	Director				Aug 9, 2021
James Aloysius Brady	Director				Apr 29, 2024
Lisa Deschamps	Director				Apr 29, 2024
Kenneth Cunningham	Director				Apr 29, 2024
Anders Ullman	Director				Apr 29, 2024
Michael Austwick	Director				Feb 1, 2024
Mahendra Shah	Director				Apr 29, 2024

Recent Insider Transactions by Companies or Individuals for Verona Pharma plc

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.